MEDIUM confidence: 100% data completeness, but the composite (54) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
Buy-rated share 40% → 25% over ~3 months (-15pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Aug 2026 | $7553.16 | $9030.34 | +19.6% |
| May 2026 | $7611.35 | $7878.30 | +3.5% |
| Mar 2026 | $8259.23 | $7089.43 | -14.2% |
| Oct 2025 | $8573.50 | $9378.93 | +9.4% |
| Aug 2025 | $7508.10 | $7749.81 | +3.2% |
| May 2025 | $7076.90 | $6694.59 | -5.4% |
| Feb 2025 | $6683.12 | $10111.26 | +51.3% |
| Nov 2024 | $7610.56 | $7023.01 | -7.7% |
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $276.1B— | $302.0B+9.4% | $364.5B+20.7% | $371.4B+1.9% | $371.4B+0.0% |
| EPS (dil.) | $59554.00— | $-15492.85-126.0% | $66412.00n/m | $61900.00-6.8% | $46563.00-24.8% |
| Free Cash Flow | $26.1B— | $21.8B-16.8% | $29.8B+36.9% | $11.6B-61.0% | $25.0B+115.6% |
| Gross Margin | 20.0% | 19.7%-0.3pp | 19.5%-0.2pp | 23.3%+3.8pp | 23.6%+0.3pp |
| Operating Margin | 12.7% | 13.8%+1.1pp | 13.2%-0.6pp | 16.0%+2.8pp | 15.9%-0.2pp |
| Net Margin | 32.6% | -7.5%-40.1pp | 26.4%+33.9pp | 24.0%-2.4pp | 18.0%-5.9pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth above the analyst consensus of 3.2%/yr (revenue basis).
Base free cash flow $22.1B (avg FY2023–FY2025; latest year $25.0B) · equity value $1.16T · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
Net insider -$19.5M over 180 days (7 open-market buys, 1 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
The QScore of 54 for BRK-A suggests a neutral outlook, with the stock's short-term score exceeding its long-term score by 7 points. BRK-A scores high on momentum, driven by its 14.4% return over the past year and a bullish 50-day versus 200-day moving average trend. However, the stock's growth and profitability scores are weighed down by negative EPS growth and moderate return on equity near 12%. The stock trades at a relatively modest valuation, with a P/E of 13.7x and P/B of 1.6x.